CytomX Therapeutics, Inc. (CTMX)

CytomX Therapeutics Revenue

In the year 2025, CytomX Therapeutics had annual revenue of $76.20M, down -44.82%. CytomX Therapeutics had revenue of $663.00K in the quarter ending December 31, 2025, a decrease of -98.26%.

• Revenue (ttm): $76.20M
• Revenue Growth: -44.82%
• P/S Ratio: 12.77
• Revenue / Employee: $1,104,362
• Employees: 69
• Market Cap: 969.56M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	76.20M	-61.90M	-44.82%
Dec 31, 2024	138.10M	36.89M	36.45%
Dec 31, 2023	101.21M	48.05M	90.38%
Dec 31, 2022	53.16M	15.85M	42.48%
Dec 31, 2021	37.31M	-31.12M	-45.47%
Dec 31, 2020	68.43M	41.53M	154.36%
Dec 31, 2019	26.90M	-32.60M	-54.79%
Dec 31, 2018	59.50M	-12.12M	-16.92%
Dec 31, 2017	71.62M	58.78M	457.59%
Dec 31, 2016	12.85M	6.90M	116.21%
Dec 31, 2015	5.94M	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	888.00K	-	-